Last filing: Jul 16, 2026. Most recent sale before this period: Feb 27, 2025.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- Last sale before this period: Feb 27, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Cytokinetics Inc (CYTK) | Director | Aug 20, 2025 | Jul 16, 2026 |
| Madrigal Pharmaceuticals, Inc. (MDGL) | Director | Jul 1, 2019 | Jun 18, 2026 |
| Incyte (INCY) | Former EVP, Chief Commercial Officer | Oct 23, 2012 | Jun 25, 2015 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 15, 2026, Cytokinetics Inc: 151 shares awarded. 1 filing: 1
- Jun 17, 2026, Madrigal Pharmaceuticals, Inc.: 454 shares granted. 1 filing: 1
- May 27, 2026, Cytokinetics Inc: 2,851 shares awarded. 1 filing: 1
- Apr 15, 2026, Cytokinetics Inc: 191 shares awarded. 1 filing: 1
- Jan 15, 2026, Cytokinetics Inc: 197 shares awarded. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.